Interleukin-33 Predicts Poor Prognosis and Promotes Renal Cell Carcinoma Cell Growth Through its Receptor ST2 and the JNK Signaling Pathway

Interleukin-33 Predicts Poor Prognosis and Promotes Renal Cell Carcinoma Cell Growth Through its Receptor ST2 and the JNK Signaling Pathway

Background/Aims: Renal cell carcinoma (RCC) is currently the ninth most common cancer in men. Interleukin (IL)-33 expression has previously been associated with a number of cancers; however, its biological role in RCC is poorly understood. In this study, we sought to elucidate the role of IL-33 in R...

Full description

Bibliographic Details
Main Authors: Chang-wen Wu, Yi-guo Wu, Cheng Cheng, Zheng-dong Hong, Zi-min Shi, Shuang-quan Lin, Jie Li, Xiao-yi He, An-yi Zhu
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-05-01
Series:Cellular Physiology and Biochemistry
Subjects:
Renal cell carcinoma
IL-33
ST2
JNK
Prognosis
Online Access:https://www.karger.com/Article/FullText/489766

Similar Items

Similar Items